Global Transdermal Medical Patch Market Research Report 2021

1 Transdermal Medical Patch Market Overview

• 1.1 Product Overview and Scope of Transdermal Medical Patch
• 1.2 Transdermal Medical Patch Segment by Type
  • 1.2.1 Global Transdermal Medical Patch Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Methyl Salicylate-Based Patch
  • 1.2.3 Rivastigmine Patch
  • 1.2.4 Fentanyl Patch
  • 1.2.5 Lidocaine Patch
  • 1.2.6 Diclofenac Patch
  • 1.2.7 Nicotine Patch
  • 1.2.8 Others
• 1.3 Transdermal Medical Patch Segment by Application
  • 1.3.1 Transdermal Medical Patch Sales Comparison by Application: (2021-2027)
  • 1.3.2 Offline Channel
  • 1.3.3 Online Channel
• 1.4 Global Transdermal Medical Patch Market Size Estimates and Forecasts
  • 1.4.1 Global Transdermal Medical Patch Revenue 2016-2027
  • 1.4.2 Global Transdermal Medical Patch Sales 2016-2027
  • 1.4.3 Transdermal Medical Patch Market Size by Region: 2016 Versus 2021 Versus 2027

2 Transdermal Medical Patch Market Competition by Manufacturers

• 2.1 Global Transdermal Medical Patch Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Transdermal Medical Patch Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Transdermal Medical Patch Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Transdermal Medical Patch Manufacturing Sites, Area Served, Product Type
• 2.5 Transdermal Medical Patch Market Competitive Situation and Trends
  • 2.5.1 Transdermal Medical Patch Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Transdermal Medical Patch Players Market Share by Revenue
  • 2.5.3 Global Transdermal Medical Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Transdermal Medical Patch Retrospective Market Scenario by Region

• 3.1 Global Transdermal Medical Patch Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Transdermal Medical Patch Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Transdermal Medical Patch Market Facts & Figures by Country
  • 3.3.1 North America Transdermal Medical Patch Sales by Country
  • 3.3.2 North America Transdermal Medical Patch Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Transdermal Medical Patch Market Facts & Figures by Country
  • 3.4.1 Europe Transdermal Medical Patch Sales by Country
  • 3.4.2 Europe Transdermal Medical Patch Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Transdermal Medical Patch Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Transdermal Medical Patch Sales by Region
  • 3.5.2 Asia Pacific Transdermal Medical Patch Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Transdermal Medical Patch Market Facts & Figures by Country
  • 3.6.1 Latin America Transdermal Medical Patch Sales by Country
  • 3.6.2 Latin America Transdermal Medical Patch Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Transdermal Medical Patch Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Transdermal Medical Patch Sales by Country
  • 3.7.2 Middle East and Africa Transdermal Medical Patch Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Transdermal Medical Patch Historic Market Analysis by Type

• 4.1 Global Transdermal Medical Patch Sales Market Share by Type (2016-2021)
• 4.2 Global Transdermal Medical Patch Revenue Market Share by Type (2016-2021)
• 4.3 Global Transdermal Medical Patch Price by Type (2016-2021)

5 Global Transdermal Medical Patch Historic Market Analysis by Application

• 5.1 Global Transdermal Medical Patch Sales Market Share by Application (2016-2021)
• 5.2 Global Transdermal Medical Patch Revenue Market Share by Application (2016-2021)
• 5.3 Global Transdermal Medical Patch Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Hisamitsu Pharmaceutical
  • 6.1.1 Hisamitsu Pharmaceutical Corporation Information
  • 6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
  • 6.1.3 Hisamitsu Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Hisamitsu Pharmaceutical Product Portfolio
  • 6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
• 6.2 Johnson & Johnson
  • 6.2.1 Johnson & Johnson Corporation Information
  • 6.2.2 Johnson & Johnson Description and Business Overview
  • 6.2.3 Johnson & Johnson Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Johnson & Johnson Product Portfolio
  • 6.2.5 Johnson & Johnson Recent Developments/Updates
• 6.3 Novartis
  • 6.3.1 Novartis Corporation Information
  • 6.3.2 Novartis Description and Business Overview
  • 6.3.3 Novartis Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Novartis Product Portfolio
  • 6.3.5 Novartis Recent Developments/Updates
• 6.4 UCB Pharma
  • 6.4.1 UCB Pharma Corporation Information
  • 6.4.2 UCB Pharma Description and Business Overview
  • 6.4.3 UCB Pharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 UCB Pharma Product Portfolio
  • 6.4.5 UCB Pharma Recent Developments/Updates
• 6.5 Mylan
  • 6.5.1 Mylan Corporation Information
  • 6.5.2 Mylan Description and Business Overview
  • 6.5.3 Mylan Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Mylan Product Portfolio
  • 6.5.5 Mylan Recent Developments/Updates
• 6.6 Teva Pharmaceutical
  • 6.6.1 Teva Pharmaceutical Corporation Information
  • 6.6.2 Teva Pharmaceutical Description and Business Overview
  • 6.6.3 Teva Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Teva Pharmaceutical Product Portfolio
  • 6.6.5 Teva Pharmaceutical Recent Developments/Updates
• 6.7 Nitto Denko
  • 6.6.1 Nitto Denko Corporation Information
  • 6.6.2 Nitto Denko Description and Business Overview
  • 6.6.3 Nitto Denko Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Nitto Denko Product Portfolio
  • 6.7.5 Nitto Denko Recent Developments/Updates
• 6.8 Grünenthal
  • 6.8.1 Grünenthal Corporation Information
  • 6.8.2 Grünenthal Description and Business Overview
  • 6.8.3 Grünenthal Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Grünenthal Product Portfolio
  • 6.8.5 Grünenthal Recent Developments/Updates
• 6.9 IBSA Group
  • 6.9.1 IBSA Group Corporation Information
  • 6.9.2 IBSA Group Description and Business Overview
  • 6.9.3 IBSA Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 IBSA Group Product Portfolio
  • 6.9.5 IBSA Group Recent Developments/Updates
• 6.10 GSK
  • 6.10.1 GSK Corporation Information
  • 6.10.2 GSK Description and Business Overview
  • 6.10.3 GSK Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 GSK Product Portfolio
  • 6.10.5 GSK Recent Developments/Updates
• 6.11 Luye Pharma Group
  • 6.11.1 Luye Pharma Group Corporation Information
  • 6.11.2 Luye Pharma Group Transdermal Medical Patch Description and Business Overview
  • 6.11.3 Luye Pharma Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Luye Pharma Group Product Portfolio
  • 6.11.5 Luye Pharma Group Recent Developments/Updates
• 6.12 Pfizer
  • 6.12.1 Pfizer Corporation Information
  • 6.12.2 Pfizer Transdermal Medical Patch Description and Business Overview
  • 6.12.3 Pfizer Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Pfizer Product Portfolio
  • 6.12.5 Pfizer Recent Developments/Updates
• 6.13 Chattem
  • 6.13.1 Chattem Corporation Information
  • 6.13.2 Chattem Transdermal Medical Patch Description and Business Overview
  • 6.13.3 Chattem Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Chattem Product Portfolio
  • 6.13.5 Chattem Recent Developments/Updates
• 6.14 Dr Reddy’s Laboratories
  • 6.14.1 Dr Reddy’s Laboratories Corporation Information
  • 6.14.2 Dr Reddy’s Laboratories Transdermal Medical Patch Description and Business Overview
  • 6.14.3 Dr Reddy’s Laboratories Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Dr Reddy’s Laboratories Product Portfolio
  • 6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
• 6.15 Bayer
  • 6.15.1 Bayer Corporation Information
  • 6.15.2 Bayer Transdermal Medical Patch Description and Business Overview
  • 6.15.3 Bayer Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Bayer Product Portfolio
  • 6.15.5 Bayer Recent Developments/Updates
• 6.16 Mundipharma
  • 6.16.1 Mundipharma Corporation Information
  • 6.16.2 Mundipharma Transdermal Medical Patch Description and Business Overview
  • 6.16.3 Mundipharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Mundipharma Product Portfolio
  • 6.16.5 Mundipharma Recent Developments/Updates
• 6.17 Endo International
  • 6.17.1 Endo International Corporation Information
  • 6.17.2 Endo International Transdermal Medical Patch Description and Business Overview
  • 6.17.3 Endo International Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Endo International Product Portfolio
  • 6.17.5 Endo International Recent Developments/Updates
• 6.18 Beijing Tide Pharmaceutical
  • 6.18.1 Beijing Tide Pharmaceutical Corporation Information
  • 6.18.2 Beijing Tide Pharmaceutical Transdermal Medical Patch Description and Business Overview
  • 6.18.3 Beijing Tide Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Beijing Tide Pharmaceutical Product Portfolio
  • 6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates

7 Transdermal Medical Patch Manufacturing Cost Analysis

• 7.1 Transdermal Medical Patch Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Transdermal Medical Patch
• 7.4 Transdermal Medical Patch Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Transdermal Medical Patch Distributors List
• 8.3 Transdermal Medical Patch Customers

9 Transdermal Medical Patch Market Dynamics

• 9.1 Transdermal Medical Patch Industry Trends
• 9.2 Transdermal Medical Patch Growth Drivers
• 9.3 Transdermal Medical Patch Market Challenges
• 9.4 Transdermal Medical Patch Market Restraints

10 Global Market Forecast

• 10.1 Transdermal Medical Patch Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Transdermal Medical Patch by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Transdermal Medical Patch by Type (2022-2027)
• 10.2 Transdermal Medical Patch Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Transdermal Medical Patch by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Transdermal Medical Patch by Application (2022-2027)
• 10.3 Transdermal Medical Patch Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Transdermal Medical Patch by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Transdermal Medical Patch by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List